Actively Recruiting
Emergent Bilinguals: the Relationship Between Child Language Proficiency and Language of Treatment on the Outcomes Children with Developmental Language Disorder
Led by University of Houston · Updated on 2025-03-10
40
Participants Needed
1
Research Sites
30 weeks
Total Duration
On this page
Sponsors
U
University of Houston
Lead Sponsor
N
National Institute on Deafness and Other Communication Disorders (NIDCD)
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are studying children aged 4 to 6 years who are emergent bilinguals with Developmental Language Disorder (DLD), a condition that affects language learning and use. This study aims to understand how a child's proficiency in Spanish and English relates to the language used during speech therapy. Since bilingual children vary in language ability and severity of DLD, the research seeks to guide speech-language pathologists on whether to use monolingual or interleaved bilingual intervention to improve language skills and academic success. The study compares two types of speech therapy involving sentence recasts, an established method for treating grammatical difficulties. One group receives monolingual therapy entirely in the child's dominant language (Spanish or English), while the other group receives interleaved therapy alternating between dominant and non-dominant languages every few minutes. Both therapies are delivered by trained bilingual speech-language pathologists over 16 hours spread across 9 weeks, targeting specific language structures through frequent, attention-focused recasts. Participants will be assessed on their language abilities before, during, and after treatment using tasks that measure accuracy in producing specific sentence structures and general language complexity. Researchers will collect data approximately one month before treatment, midway, and two weeks after therapy completion. The study also monitors language development progress and the ability to benefit from treatment in both languages, ensuring children meet hearing and cognitive requirements. The total participation duration spans the 9-week treatment and the assessment periods.
CONDITIONS
Brief Title
Emergent Bilinguals: Child Language Proficiency and Language of Treatment
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Parent concerns or history of receiving language services in public schools
- Age between 4 and 6 years meeting specific language test cutoffs for best language
- Nonverbal IQ score of 70 or higher on the Kaufman Brief Intelligence Test-2
- Passing a hearing screening test
- Emergent bilingual producing simple sentences in Spanish or English and exposed to both languages
- Ability to benefit from treatment shown by less than 40% accuracy on specific language probes in both languages
You will not qualify if you...
- Children with significant sensory-motor concerns or psychiatric disorders according to parent report
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 9 weeks
Participants receive sentence recast therapy focusing on grammar, delivered by a trained bilingual speech-language pathologist. Therapy involves 16 hours spread over 9 weeks with recasts at a rate of about 1 per minute. Treatment is provided either entirely in the child's dominant language or interleaved between dominant and non-dominant languages depending on the assigned group.
Multiple therapy sessions spread over 9 weeks
Duration - 2 weeks
Participants complete outcome assessments approximately 2 weeks after treatment ends to measure language proficiency improvements.
1 follow-up visit (in-person)
Trial Site Locations
Total: 1 location
1
University of Houston
Houston, Texas, United States, 77204
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here